China NT Pharma Group Company Limited

HKEX:1011.HK

0.305 (HKD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019201820172016201520142013201220112010
Operating Activities:
Net Income -126.609-54.296-148.752-368.933-583.472-923.902177.512156.603100.70517.327-652.841-1,177.288307.469210.158
Depreciation & Amortization 5.88121.0742.24924.39731.13135.64734.42123.00615.92823.16427.08227.62424.24317.424
Deferred Income Tax 00-12.317140.249457.426610.645-6.9254.4934.772-34.573430.92645.106-65.29-85.58
Stock Based Compensation 37.7090.6040.0840.1017.4628.267.6382.6257.4410.470.204-3.55311.45424.806
Change In Working Capital 81.517-12.189-92.177135.4232.874-238.713-96.389-191.002-255.5838.662102.918447.597-542.285-595.422
Accounts Receivables 67.329-32.1077.94126.5392.749-126.546-221.983-280.59171.893-78.231331.873000
Inventory -2.52819.884-5.1886.7828.144.231100.3385.74-91.02643.497-49.657-7.865165.368-298.095
Accounts Payables 032.107-7.941-26.539-2.749126.546221.983280.591-71.89378.231-331.873000
Other Working Capital 16.716-32.073-86.989128.641-5.266-242.94425.25683.849-236.4543.396-179.298455.462-707.653-297.327
Other Non Cash Items 48.95781.02176.13894.967132.344383.8631.30424.971-0.66157.67353.23753.67258.08345.379
Operating Cash Flow 50.47636.21-134.77526.20447.765-124.203147.56120.693-97.39872.723-38.48-6.842-206.326-383.235
Investing Activities:
Investments In Property Plant And Equipment -12.893-4.494-0.646-23.844-87.201-240.886-346.638-724.203-41.988-118.192-18.117-65.462-43.57-52.847
Acquisitions Net -0.1979200.144557.341-74.77268-21-21.078-81.25200000
Purchases Of Investments 000-44.7900-0.533-123.079-30000
Sales Maturities Of Investments 00044.7900-280.654-696.189300000
Other Investing Activites -9.2230.02458.31662.105-44.90229.643404.734599.2536.992206.663-107.1116.426-61.394-4.752
Investing Cash Flow -22.144.53257.814595.602-206.875-143.243-244.091-854.22-80.16985.471-125.228-59.036-104.964-57.599
Financing Activities:
Debt Repayment -18.174-80.479-162.248-1,736.384-1,068.4-1,198.257-736.446-439.112-639.091-366.179-294.014-1,016.434-1,906.793-1,776.263
Common Stock Issued 9.3932.0210001,491.5550.3660.27553.248000.054933.7860
Common Stock Repurchased 0000-1.046-8.787-31.854-5.504-11.30400000
Dividends Paid 00000-56.709-33.954-13.249000000
Other Financing Activities -9.8531.78237.451,112.1391,170.819-8.787950.7751,041.359255.525323.298442.98954.3331,516.2712,154.367
Financing Cash Flow -28.972-46.676-124.798-624.245101.373219.015148.887583.764158.378-42.881148.966-62.047543.264378.104
Other Information:
Effect Of Forex Changes On Cash 0.243.4883.366-17.923-1.858-10.6444.88711.3921.1221.51-2.0490.2-8.0290.3
Net Change In Cash -0.396-2.4481.607-20.362-59.595-59.07557.244-238.371-18.067116.823-16.791-127.725223.945-62.43
Cash At End Of Period 1.521.9169.4437.83628.19887.793146.86889.624327.995346.062229.239246.03373.755149.81